Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations

Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%–13% are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) considered the most predominant. Among the first‐line antituberculosis drug...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luis Jaramillo‐Valverde, Kelly S. Levano, David D. Tarazona, Silvia Capristano, Cesar Sanchez, Julio A. Poterico, Eduardo Tarazona‐Santos, Heinner Guio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-06-01
Colecção:	Pharmacology Research & Perspectives
Assuntos:	genotype native and mestizo population Pharmacogenetic tuberculosis
Acesso em linha:	https://doi.org/10.1002/prp2.1179
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!